COL4A2 and glioma: Correlation analyses were performed using Spearman's Rho, and survival analyses (5-year overall survival and 1-year progression-free survival) were performed using Kaplan-Meier curves, log-rank test and multivariate proportional hazard models.<h4>Results</h4>The levels of p120-catenin significantly increased with the degree of glioma malignancy (p<0.001; Rho=0.599), while the opposite was observed for COL4A2 (p<0.001, Rho=-0.387) and SOX10 (p<0.001; Rho=-0.293).